✨ Your Portfolio is fetched and updated from zerodha.
Nano Agriculture

Indrayani Biotech Ltd.

INDRANIB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹64 Cr.
P/E
0.00

Indrayani Biotech Ltd.

  • Indrayani Biotech
  • Trescon
  • Raghuvansh Agro

FAQs on Indrayani Biotech Ltd. Shareprice

Indrayani Biotech has given lower returns compared to its competitors.
Indrayani Biotech has grown at ~-46.86% over the last 3yrs while peers have grown at a median rate of -5.88%

Indrayani Biotech is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Indrayani Biotech is 0.0, while 3 year average PE is 25.52.
Also latest EV/EBITDA of Indrayani Biotech is 37.75 while 3yr average is 20.63.

View FAQ's On Business

Growth Table

  • Indrayani Biotech Ltd.
  • Trescon
  • Raghuvansh Agro

Balance Sheet

  • Indrayani Biotech Ltd.
  • Trescon
  • Raghuvansh Agro

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Indrayani Biotech Ltd.
  • Trescon
  • Raghuvansh Agro

Cash Flow

  • Indrayani Biotech Ltd.
  • Trescon
  • Raghuvansh Agro

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Indrayani Biotech Ltd.
  • Trescon
  • Raghuvansh Agro

Quarterly Results

  • Indrayani Biotech Ltd.
  • Trescon
  • Raghuvansh Agro

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Indrayani Biotech Ltd. Financials

Indrayani Biotech balance sheet is weak and might have solvency issues

Yes, The net debt of Indrayani Biotech is increasing.
Latest net debt of Indrayani Biotech is ₹137 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹107 Crs.

No, profit is decreasing.
The profit of Indrayani Biotech is -₹6.8 Crs for TTM, -₹1.56 Crs for Mar 2025 and ₹6.36 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Indrayani Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech